In humanized mouse models of orthotopic PC, treatment with these Engineered DCs led to significant tumor reduction, increased tumor-infiltrating lymphocytes (CD4+ and CD8+ T cells), and improved survival. This evidence concerns the gene CD8A and neoplasm.